Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
leon-nanodrugs has developed and commercialized proprietary GMP-compliant devices based on its FR-JET technology for efficient, scalable production of lipid nanoparticles and other nanocarriers. These systems enable rapid process development through to large-scale commercial supply, supporting advanced therapies such as mRNA vaccines and personalized medicines. The technology is validated with high reproducibility and throughput, addressing key bottlenecks in nanoparticle drug delivery manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on leon-nanodrugs.